Cite
HARVARD Citation
Marwitz, S. et al. (2021). Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer. Journal for immunotherapy of cancer. 9 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marwitz, S. et al. (2021). Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer. Journal for immunotherapy of cancer. 9 (2), p. . [Online].